Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats
Introduction
Melanin-concentrating hormone (MCH) is a nonadecapeptide with an amino acid sequence highly conserved among fish, rats and humans (Vaughan et al., 1989). MCH was first isolated from chum salmon pituitary and shown to regulate melanin pigment aggregation in melanocytes (Kawauchi et al., 1983). Neuroanatomical studies in the rat demonstrated that MCH gene expression is restricted to the lateral hypothalamic area and zona incerta with extensive fiber projections throughout the brain (Bittencourt et al., 1992). Lesions of the lateral hypothalamic area produce profound hypophagia and extreme weight loss in rodents, indicating its importance in feeding regulation Teitelbaum et al., 1969, Bernardis and Bellinger, 1996.
Many studies suggest that MCH plays a role in feeding and energy metabolism in rodents (for review, see Griffond and Baker, 2002, Boutin et al., 2002). Central administration of MCH promotes feeding in rats and mice Qu et al., 1996, Rossi et al., 1997 and antagonizes the actions of alpha-melanocyte-stimulating hormone (α-MSH), an anorexigenic melanocortin peptide Sanchez et al., 1997, Grill et al., 1998, Ludwig et al., 1998. The adipocyte hormone leptin inhibits hypothalamic MCH gene expression Shimada et al., 1998, Kokkotou et al., 2001 while fasting increases hypothalamic MCH mRNA levels in both leptin-deficient ob/ob and wild type mice Qu et al., 1996, Kokkotou et al., 2001. Importantly, prepro-MCH-deficient mice are lean, hypophagic and have an increased metabolic rate (Shimada et al., 1998) in contrast to transgenic mice over-expressing the prepro-MCH gene which develop hyperphagia and mild obesity on a high-fat diet (Ludwig et al., 2001).
Two G-protein coupled receptors for MCH have been identified, MCH-1 and MCH-2 receptors, however, only MCH-1 receptor is found in rodents Saito et al., 2000, An et al., 2001, Hill et al., 2001, Mori et al., 2001, Sailer et al., 2001, Wang et al., 2001, Tan et al., 2002. Both MCH receptors are selective for MCH and are not activated by other neuropeptide derivatives of the prepro-MCH gene, including neuropeptide E-I (NEI), neuropeptide G-E (NGE) and MCH-gene-overprinted-polypeptide (MGOP) Sailer et al., 2001, Saito et al., 1999, Chambers et al., 1999. MCH-1 receptor mRNA and protein are located in rat cerebral cortex, caudate putamen, hippocampus, amygdala, hypothalamus and thalamus Hervieu et al., 2002, Saito et al., 2001. MCH-1 receptor deficient (Mch1r−/−) mice are lean (like pre-pro-MCH deficient mice), but are hyperphagic when maintained on regular chow Chen et al., 2002, Marsh et al., 2002. Mch1r−/−mice are less susceptible to diet-induced obesity due to their hyperactivity and increased energy expenditure Chen et al., 2002, Marsh et al., 2002. In addition, the MCH-1 receptor is essential for the orexigenic effects of MCH in mice (Marsh et al., 2002).
To better understand the physiological function of the MCH-1 receptor in mammals, we utilized a potent MCH-1 receptor agonist peptide, Compound A, a truncated analog of MCH which efficiently binds to and activates MCH-1 and MCH-2 receptors (detailed in Bednarek et al., 2001, Bednarek et al., 2002a) and a selective MCH-1 receptor antagonist peptide, Compound B (Bednarek et al., 2002b). Here we characterize the acute effects of the novel MCH-1 receptor agonist and the selective MCH-1 receptor antagonist on food intake, body temperature and locomotor activity in rats. In addition, in lean rats we evaluate the effects of chronic intracerebroventricular infusions of the MCH 1 receptor agonist, Compound A, the MCH-1 receptor antagonist, Compound B, and neuropeptide Y on food intake, body weight, plasma hormone levels, body composition and on MCH, pro-opiomelanocortin (POMC), neuropeptide Y and melanocortin MC4 receptor hypothalamic gene expression.
Section snippets
Animals
Male Sprague–Dawley rats with indwelling stainless steel guide cannulas placed intracerebroventricularly (i.c.v.) into the right lateral ventricle of the brain were purchased from Charles River Laboratories (Wilmington, DE). Rats were housed singly in a temperature-and humidity-controlled room with a 12:12 light–dark cycle (4:00 p.m. EST lights off). Rats were maintained with ad libitum access to water and regular pelleted rat chow (Harlan Teklad, Madison, WI, Diet 7012, 14.8% kcal from fat)
Acute food intake effects of Compound A
In pre-fed rats, i.c.v. administration of the MCH-1 receptor agonist Compound A increased food consumption in a dose-and time-dependent manner over the 18 h duration of the study. In comparison to vehicle-treatment, the acute orexigenic effects of Compound A were most evident within the first 6 h following peptide administration (Fig. 2). The extents of the increases in food intake evoked by Compound A at 1, 5 and 15 μg were +315% (P<0.01), +409% (P<0.05) and +611% (P<0.01), respectively, at 3
Discussion
Here we show that central administration of the MCH-1 receptor agonist Compound A into the lateral ventricle of satiated rats prior to dark onset increases food intake and that this hyperphagia can be blocked pharmacologically by the MCH-1 receptor antagonist Compound B. We used a moderate high fat (MHF) diet in our studies because we determined empirically that it provided a substantially bigger window for detecting effects of the MCH-1 receptor peptides on food intake over regular, low fat
References (43)
- et al.
Synthesis and biological evaluation in vitro of selective high affinity peptide agonist of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1
J. Biol. Chem.
(2002) - et al.
The lateral hypothalamic area revisited: ingestive behavior
Neurosci. Biobehav. Rev.
(1996) - et al.
Isolation and characterization of the human melanin-concentrating hormone gene and a variant gene
Mol. Brain Res.
(1993) - et al.
Cell and molecular biology of melanin-concentrating hormone
Int. Rev. Cytol.
(2002) - et al.
Molecular cloning and functional characterization of MCH2, a novel human MCH receptor
J. Biol. Chem.
(2001) - et al.
NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of insulin and leptin
Regul. Pept.
(1998) - et al.
Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor
Biochem. Biophys. Res. Comm.
(2001) - et al.
Central effects of neuromedin U in the regulation of energy homeostasis
Biochem. Biophys. Res. Commun.
(2000) - et al.
Melanin-concentrating hormone receptor: an orphan receptor fits the key
Trends Endocrinol. Metab.
(2000) - et al.
Melanin-concentrating hormone (MCH) antagonizes the effects of α-MSH and neuropeptide E-I on grooming and locomotor activities in the rat
Peptides
(1997)
Expression of basic helix-loop-helix PAS genes in the mouse suprachiasmatic nucleus
Neuroscience
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression
Genomics
Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2
J. Biol. Chem.
Identification and characterization of a melanin-concentrating hormone receptor
Proc. Natl. Acad. Sci. U.S.A.
Central thermoregulatory effects of neuropeptide Y and orexin A in rats
Acta Physiol. Hung.
Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2
Biochemistry
Synthesis and biological evaluation in vitro of selective high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1
Biochemistry
The melanin-concentrating hormone system of the rat brain: an immuno-and hybridization histochemical characterization
J. Comp. Neurol.
Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist
Nat. Med.
Melanin-concentrating hormone and its receptors: state of the art
Can. J. Physiol. Pharmacol.
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein coupled receptor SLC-1
Nature
Cited by (160)
Melanin-concentrating hormone and food intake control: Sites of action, peptide interactions, and appetition
2021, PeptidesCitation Excerpt :Acting through MCH1R [15], MCH promotes overall energy conservation and/or surplus by increasing food intake and/or reducing energy expenditure [16–18]. Extensive evidence, including from a seminal study in 1996 [8], shows that elevating MCH generally in the brain, either through ventricular administration (ICV) [19–22] or transgenic MCH overexpression [16] increases food intake, while ICV injection of MCH1R antagonists reduce food intake [10]. Moreover, these increases occur regardless of the food’s palatability and/or obesity-promoting effects [23].
Nicotine’ actions on energy balance: Friend or foe?
2021, Pharmacology and TherapeuticsReceptor Transduction Pathways Mediating Hormone Action
2020, Sperling Pediatric Endocrinology: Expert Consult - Online and PrintPostnatal overnutrition alters the orexigenic effects of melanin-concentrating hormone (MCH) and reduces MCHR1 hypothalamic expression on spontaneous feeding and fasting
2018, Pharmacology Biochemistry and Behavior